Improved loss from operations by 31% - - Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health ...

Brian Kemp Dolliver; Analyst; Brookline Capital Markets Douglas Tsao; Analyst; H.C. Wainwright & Co LLC ...

Post-election, leaders from Cadence OTC, Evvy, Flora Fertility, G2G Consulting, and Winx Health share their summary of and ...

The best time to take probiotics may depend on your needs and reasons for using the supplements. Learn everything you need to ...

HOLX's strength in the Molecular Diagnostics wing instills optimism among investors. Yet, macro woes and currency impacts raise concerns.

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

The FDA has accepted for review the resubmitted BLA for prademagene zamikeracel for recessive dystrophic epidermolysis bullosa.

The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first ...

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...